Sue Li

机构：Brigham and Women's Hospital, Massachusetts General Hospital · ORCID：0000-0002-5388-8336

发表论文 37 篇 · 总被引 2126 次 · h-index 18

代表论文

• Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial (2020 · The Lancet HIV · 被引 181)
• Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial (2018 · PLoS Medicine · 被引 176)
• Comprehensive Analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 Loci and Squamous Cell Cervical Cancer Risk (2008 · Cancer Research · 被引 136)
• Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077 (2020 · AIDS and Behavior · 被引 95)
• First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090) (2015 · Open Forum Infectious Diseases · 被引 66)
• Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial (2014 · Journal of Virology · 被引 65)